In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Alphatec Holdings (NASDAQ: ATEC), with a price target of $4. The company’s shares closed yesterday at $2.74.
According to TipRanks.com, Ramakanth is a 4-star analyst with an average return of 6.4% and a 38.8% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals Inc, IntelGenx Technologies, and Leap Therapeutics Inc.
Currently, the analyst consensus on Alphatec Holdings is a Moderate Buy with an average price target of $4.
See today’s analyst top recommended stocks >>
The company has a one-year high of $4.27 and a one-year low of $1.58. Currently, Alphatec Holdings has an average volume of 112.5K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Alphatec Holdings, Inc. designs, develops, and markets spinal fusion technology products and solutions for the treatment of spinal disorders. The company products portfolio include biologics, cervical, interbody, minimally invasive surgery, and thoracolumbar. It operates through the United States and International geographical segments.
